open access

Vol 6, Supp. A (2010)
suplement
Published online: 2010-11-22
Get Citation

The use of liposomal doxorubicin (Myocet®) in the treatment of advanced breast cancer in 87-year-old woman

Piotr Sawrycki

open access

Vol 6, Supp. A (2010)
suplement
Published online: 2010-11-22

Abstract

Liposomal doxorubicin is used in treatment of advanced breast cancer. Structure of drug molecule allows delivery of greater total doxorubicin’s dose without escalation of adverse events. In this article treatment of elderly patient with advanced breast cancer treated before with several regimens of chemotherapy is described. After application of Myocet® clinical regression lasted several months with important reduction of symptoms have been achieved. Tolerance of treatment was good. Until progression there were no events disrupting the rhythm and the planned dose of chemotherapy.
Onkol. Prak. Klin. 2010; supl. A: A51–A53

Abstract

Liposomal doxorubicin is used in treatment of advanced breast cancer. Structure of drug molecule allows delivery of greater total doxorubicin’s dose without escalation of adverse events. In this article treatment of elderly patient with advanced breast cancer treated before with several regimens of chemotherapy is described. After application of Myocet® clinical regression lasted several months with important reduction of symptoms have been achieved. Tolerance of treatment was good. Until progression there were no events disrupting the rhythm and the planned dose of chemotherapy.
Onkol. Prak. Klin. 2010; supl. A: A51–A53
Get Citation

Keywords

advanced breast cancer; liposomal doxorubicin; chemotherapy

About this article
Title

The use of liposomal doxorubicin (Myocet®) in the treatment of advanced breast cancer in 87-year-old woman

Journal

Oncology in Clinical Practice

Issue

Vol 6, Supp. A (2010)

Pages

51-53

Published online

2010-11-22

Keywords

advanced breast cancer
liposomal doxorubicin
chemotherapy

Authors

Piotr Sawrycki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl